453P SLFN11 expression across lung neuroendocrine neoplasms (NENs): Small cell lung cancer (SCLC), typical and atypical carcinoids (TC/AC) and large cell neuroendocrine carcinoma (LCNEC)
Year: 2026
Type: article
Study design: Observational Study
Abstract: SLFN11 is highly expressed in SCLC and predicts sensitivity to DNA-damaging agents, however its role in other lung NENs (TC/AC, LCNEC) is unknown. TC/AC may be subtyped into A1, A2 and B based on OTP, ASCL1 and HNF1A expression (exp); LCNEC and SCLC may be classified through NEUROD1, ASCL1, POU2F3, and YAP1 (NAPY)exp. This multicentre study assessed SLFN11 across lung NENs and explored its molecular and clinical associations.
Source: ESMO Open
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W7137884124
FWCI:
Cites:
Cited by:
Related to:
